Hydrus microstent wins FDA approval
- Posted on: Aug 16 2018
- Leave a response
The FDA has approved the use of the Hydrus microstent in conjunction with cataract surgery to reduce IOP in patients with mild to moderate primary open-angle glaucoma.
Source: AAO
Posted in: Uncategorized
